Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-01-28, Stock:ABBV, The news for the past five days is as follows:
2019-01-18: NEWS1: AbbVie's Imbruvica fails to meet main goal in pancreatic cancer study.NEWS2: AbbVie's cancer drug fails to meet main goal in late-stage study.NEWS3: AbbVie Provides Update on Phase 3 Study of Ibrutinib (IMBRUVICA®) in Metastatic Pancreatic Cancer.NEWS4: These 3 Biotech Stocks Appear Poised To Beat Fourth-Quarter Forecasts.NEWS5: Can AbbVie (ABBV) Keep the Earnings Surprise Streak Alive?.NEWS6: Can AbbVie (ABBV) Keep the Earnings Surprise Streak Alive?.NEWS7: AbbVie (ABBV) Reports Next Week: Wall Street Expects Earnings Growth.NEWS8: AbbVie (ABBV) Reports Next Week: Wall Street Expects Earnings Growth.NEWS9: AbbVie (ABBV) Reports Next Week: Wall Street Expects Earnings Growth.NEWS10: Can AbbVie (ABBV) Keep the Earnings Surprise Streak Alive?.NEWS11: Pacira's Study on Exparel Label Expansion Meets Endpoints.NEWS12: Pacira's Study on Exparel Label Expansion Meets Endpoints.NEWS13: Are you a Tortoise or a Hare Investor?.NEWS14: Are you a Tortoise or a Hare Investor?.NEWS15: Zacks Market Edge Highlights: Occidental, Gilead, AbbVie, AT&T and Verizon.NEWS16: Zacks Market Edge Highlights: Occidental, Gilead, AbbVie, AT&T and Verizon.NEWS17: Are you a Tortoise or a Hare Investor?.NEWS18: Pacira's Study on Exparel Label Expansion Meets Endpoints.
2019-01-22: NEWS1: 5 Amazing Earnings Charts.NEWS2: 5 Amazing Earnings Charts.NEWS3: J&J's (JNJ) Q4 Earnings Beat, 2019 Sales Forecast Soft.NEWS4: J&J's (JNJ) Q4 Earnings Beat, 2019 Sales Forecast Soft.NEWS5: 5 Amazing Earnings Charts.NEWS6: J&J's (JNJ) Q4 Earnings Beat, 2019 Sales Forecast Soft.NEWS7: Bet on These 5 Low Leverage Stocks to Secure Returns.NEWS8: See what the IHS Markit Score report has to say about AbbVie Inc..NEWS9: Better Buy: Pfizer vs. AbbVie.
2019-01-23: NEWS1: Top Research Reports for Amazon, Verizon & AbbVie.NEWS2: Is a Beat in Store for AbbVie (ABBV) This Earnings Season?.NEWS3: Is a Beat in Store for AbbVie (ABBV) This Earnings Season?.NEWS4: 3 Upcoming Readouts for Gilead Sciences You Don't Want to Miss.NEWS5: 3 Upcoming Readouts for Gilead Sciences You Don't Want to Miss.NEWS6: Is a Beat in Store for AbbVie (ABBV) This Earnings Season?.
2019-01-24: NEWS1: Is a Surprise in the Cards for Novartis (NVS) in Q4 Earnings?.NEWS2: Is a Surprise in the Cards for Novartis (NVS) in Q4 Earnings?.NEWS3: Notable Thursday Option Activity: SEAS, ABBV, TWLO.NEWS4: Notable Thursday Option Activity: SEAS, ABBV, TWLO.NEWS5: Is a Surprise in the Cards for Novartis (NVS) in Q4 Earnings?.NEWS6: Pre-Market Earnings Report for January 25, 2019 :  ABBV, NEE, CL, APD, ERIC, DHI, LEA, HRC, IBKC, NEP, ABCB, ESXB.NEWS7: Pre-Market Earnings Report for January 25, 2019 :  ABBV, NEE, CL, APD, ERIC, DHI, LEA, HRC, IBKC, NEP, ABCB, ESXB.NEWS8: What's Behind the Biotech ETF Rally to Start 2019?.NEWS9: What's Behind the Biotech ETF Rally to Start 2019?.NEWS10: Q4 Earnings Preview For AbbVie.NEWS11: Zacks Investment Ideas feature highlights: International Business Machines, Procter and Gamble, Ford, Intel and Abbvie.NEWS12: Zacks Investment Ideas feature highlights: International Business Machines, Procter and Gamble, Ford, Intel and Abbvie.NEWS13: The Zacks Analyst Blog Highlights: Amazon, Verizon, AbbVie, Lowe???s and Chubb.NEWS14: The Zacks Analyst Blog Highlights: Amazon, Verizon, AbbVie, Lowe???s and Chubb.NEWS15: Healthcare ETFs in Focus Ahead of Q4 Earnings.NEWS16: Healthcare ETFs in Focus Ahead of Q4 Earnings.NEWS17: Pfizer (PFE) to Report Q4 Earnings: What's in the Cards?.NEWS18: Pfizer (PFE) to Report Q4 Earnings: What's in the Cards?.NEWS19: What's Behind the Biotech ETF Rally to Start 2019?.NEWS20: Is a Surprise Coming for AbbVie (ABBV) This Earnings Season?.NEWS21: Is a Surprise Coming for AbbVie (ABBV) This Earnings Season?.NEWS22: iShares U.S. Healthcare ETF Experiences Big Inflow.NEWS23: iShares U.S. Healthcare ETF Experiences Big Inflow.NEWS24: Pfizer (PFE) to Report Q4 Earnings: What's in the Cards?.NEWS25: Healthcare ETFs in Focus Ahead of Q4 Earnings.NEWS26: The Zacks Analyst Blog Highlights: Amazon, Verizon, AbbVie, Lowe???s and Chubb.NEWS27: Zacks Investment Ideas feature highlights: International Business Machines, Procter and Gamble, Ford, Intel and Abbvie.NEWS28: Is a Surprise Coming for AbbVie (ABBV) This Earnings Season?.NEWS29: 3 Things to Expect in AbbVie's Q4 Earnings Update.NEWS30: 3 Things to Expect in AbbVie's Q4 Earnings Update.NEWS31: 3 Things to Expect in AbbVie&apos;s Q4 Earnings Update.NEWS32: AbbVie Falls 3%.
2019-01-25: NEWS1: Why Intel, AbbVie, and Vale Slumped Today.NEWS2: Why Intel, AbbVie, and Vale Slumped Today.NEWS3: Western Digital, Starbucks rise while AbbVie, Intel drop.NEWS4: AbbVie Earnings: ABBV Stock Falters on Q4 Miss.NEWS5: AbbVie Earnings: ABBV Stock Falters on Q4 Miss.NEWS6: Why Intel, AbbVie, and Vale Slumped Today.NEWS7: AbbVie Stock Crumbles After Biosimilars Take A Chunk Of Humira Sales.NEWS8: AbbVie Falls After Missing Top- and Bottom-Line Estimates.NEWS9: Health Care Sector Update for 01/25/2019: CHRS,AMGN,RMD,AZN,IDXG,ABBV.NEWS10: Health Care Sector Update for 01/25/2019: CHRS,AMGN,RMD,AZN,IDXG,ABBV.NEWS11: AbbVie Q4 Earnings: 3 Key Things You Need to Know.NEWS12: AbbVie Q4 Earnings: 3 Key Things You Need to Know.NEWS13: AbbVie Inc (ABBV) Q4 2018 Earnings Conference Call Transcript.NEWS14: AbbVie Inc (ABBV) Q4 2018 Earnings Conference Call Transcript.NEWS15: AbbVie Inc (ABBV) Q4 2018 Earnings Conference Call Transcript.NEWS16: Health Care Sector Update for 01/25/2019: AZN,IDXG,ABBV.NEWS17: Health Care Sector Update for 01/25/2019: AZN,IDXG,ABBV.NEWS18: AbbVie Q4 Earnings: 3 Key Things You Need to Know.NEWS19: Congressional Activities on Shutdown in Focus.NEWS20: Congressional Activities on Shutdown in Focus.NEWS21: Pharma Stock Roundup: JNJ & BMY's Q4 Earnings, Study Failures at LLY & ABBV.NEWS22: Pharma Stock Roundup: JNJ & BMY's Q4 Earnings, Study Failures at LLY & ABBV.NEWS23: Asia, Congress Activity, Put Futures in the Green.NEWS24: Asia, Congress Activity, Put Futures in the Green.NEWS25: AbbVie (ABBV) Misses on Q4 Earnings & Revenues, Shares Down.NEWS26: AbbVie (ABBV) Misses on Q4 Earnings & Revenues, Shares Down.NEWS27: Celgene Stock Is Rising After the CEO of AbbVie Ruled Out a Big Deal.NEWS28: AbbVie (ABBV) Misses Q4 Earnings and Revenues, Shares Down.NEWS29: AbbVie (ABBV) Misses Q4 Earnings and Revenues, Shares Down.NEWS30: Celgene Shares Rise as AbbVie CEO Rules Out Big Deal.NEWS31: [$$] Drug Maker AbbVie Swings to Loss on Charge from Stemcentrx Deal.NEWS32: AbbVie Earnings: ABBV Stock Falters on Q4 Miss.NEWS33: AbbVie expects steeper decline in Humira's overseas sales; shares fall.NEWS34: Congressional Activities on Shutdown in Focus.NEWS35: AbbVie (ABBV) Misses on Q4 Earnings & Revenues, Shares Down.NEWS36: Asia, Congress Activity, Put Futures in the Green.NEWS37: Pharma Stock Roundup: JNJ & BMY's Q4 Earnings, Study Failures at LLY & ABBV.NEWS38: Wall Street's Risk Appetite Improves on Upcoming Trade Talks, Tech Sector Gains.NEWS39: Wall Street's Risk Appetite Improves on Upcoming Trade Talks, Tech Sector Gains.NEWS40: AbbVie not contemplating big deals - CEO.NEWS41: Health Care Sector Update for 01/25/2019: IDXG, RMD, ABBV, JNJ, PFE, MRK, ABT, AMGN.NEWS42: Health Care Sector Update for 01/25/2019: IDXG, RMD, ABBV, JNJ, PFE, MRK, ABT, AMGN.NEWS43: US STOCKS-Wall St set to open higher as investors focus on upbeat earnings.NEWS44: AbbVie (ABBV) Misses Q4 Earnings and Revenues, Shares Down.NEWS45: AbbVie (ABBV) Lags Q4 Earnings and Revenue Estimates.NEWS46: AbbVie Falls 6%.NEWS47: AbbVie: 4Q Earnings Snapshot.NEWS48: AbbVie Earnings, Revenue Fall Short As Humira Sales Dive Overseas.NEWS49: Abbvie shares slide 2.3% premarket after earnings miss.NEWS50: AbbVie profit misses as Humira faces biosimilar challenge in Europe.NEWS51: AbbVie Reports Full-Year and Fourth-Quarter 2018 Financial Results.NEWS52: Earnings Reaction History: AbbVie Inc., 58.3% Follow-Through Indicator, 3.7% Sensitive.NEWS53: Earnings Reaction History: AbbVie Inc., 58.3% Follow-Through Indicator, 3.7% Sensitive.NEWS54: Top Picks 2019- AbbVie ABBV.NEWS55: Coherus Reaches Settlement With AbbVie Securing Rights To Commercialize CHS-1420.NEWS56: Coherus Reaches Settlement With AbbVie Securing Rights To Commercialize CHS-1420.NEWS57: AbbVie Q4 Results Miss View; Stock Down.NEWS58: AbbVie Q4 Results Miss View; Stock Down.NEWS59: AbbVie Earnings, Revenue miss in Q4.NEWS60: Can Allergan (AGN) Keep the Earnings Streak Alive in Q4?.NEWS61: Can Allergan (AGN) Keep the Earnings Streak Alive in Q4?.NEWS62: Can Allergan (AGN) Keep the Earnings Streak Alive in Q4?.

Answer: Decrease